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Many bacterial pathogens that cause different illnesses employ the cytolethal distending toxin (CDT) to induce host
cell DNA damage, leading to cell cycle arrest or apoptosis. CDT is a tripartite holotoxin that consists of a DNase I family
nuclease (CdtB) bound to two ricin-like lectin domains (CdtA and CdtC). Through the use of structure-based
mutagenesis, biochemical and cellular toxicity assays, we have examined several key structural elements of the CdtA
and CdtC subunits for their importance to toxin assembly, cell surface binding, and activity. CdtA and CdtC possess N-
and C-terminal nonglobular polypeptides that extensively interact with each other and CdtB, and we have determined
the contribution of each to toxin stability and activity. We have also functionally characterized two key binding
elements of the holotoxin revealed from its crystal structure. One is an aromatic cluster in CdtA, and the other is a long
and deep groove that is formed at the interface of CdtA and CdtC. We demonstrate that mutations of the aromatic
patch or groove residues impair toxin binding to HeLa cells and that cell surface binding is tightly correlated with
intoxication of cultured cells. These results establish several structure-based hypotheses for the assembly and function
of this toxin family.
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Introduction
The cytolethal distending toxin (CDT) is a tripartite
bacterial toxin that targets many types of eukaryotic cells.
Most of the cells intoxicated with CDT predominantly arrest
in G2/M transition of the cell cycle; they slowly distend over a
period of 2 5 d, and eventually die [1 4]. The effect on
lymphocyte cultures is somewhat faster and different, since
they do not distend but undergo apoptosis [5 7]. CDT activity
has been detected among many pathogenic gram-negative
bacteria that can cause a panoply of diseases such as
chancroid, endocarditis, diarrhea, periodontal disease, and
chronic hepatitis [1 4].
A major advancement in the understanding of the action
of CDT was taken with the discovery that CdtB (cytolethal
distending toxin B) shares weak active site sequence
similarity with DNase I like nucleases and that the mutation
of predicted active site residues leads to a loss of CDT
activity [8,9]. Subsequent studies demonstrated that CdtB has
weak nuclease activity in vitro [10,11] and that CDT inﬂicts
damage to eukaryotic DNA in vivo [4,5,9,10,12 15]. The
crystal structure of the CDT holotoxin from Haemophilus
ducreyi revealed that CdtB is indeed a DNase I like nuclease
in which all key residues involved in the catalysis and
binding to DNA are conserved [16]. A growing amount of
evidence supports a model of CDT intoxication by which
CdtB delivery into the cells is mediated by CdtA (cytolethal
distending toxin A) and CdtC (cytolethal distending toxin C)
[17 19]. Once inside the cell, CdtB can translocate to the
nucleus and induce DNA lesions, which will activate DNA
damage response cascades and cause cell cycle arrest
[18 20].
Very limited data are available about the function of CdtA
and especially of CdtC. Only recently have several groups
adapted different binding assays to study the interactions of
CdtA and CdtC with eukaryotic cells. Most of these assays
ﬁnd that both CdtA and CdtC are capable of binding to the
cellular membrane [21 24], and some suggested that they
might share the same receptor [22,23]. Reports indicating
that antibodies raised against CdtC were protective against
CDT toxicity corroborated these ﬁndings [25]. On the
contrary, Mao and DiRienzo [11] were not able to detect
CdtC on the cell surfaces by using immunoﬂuorescent
techniques. The crystal structure of CDT holotoxin uncov-
ered that both CdtA and CdtC are lectin-type structures,
similar to each other and to the binding component of plant
toxin ricin [16]. This realization, together with the position-
ing of lectin subunits, and the presence of two notable
surface elements at their interface, an aromatic patch and
an adjacent deep groove surface, suggest that the role of
CdtA and CdtC is to interact with the cell surface and to
enable translocation of the holotoxin across the plasma
membrane [16].
In the present report, we have used structure-guided
mutagenesis, biochemical and cellular assays, to examine
the main structural features of CdtA and CdtC. We have
discovered nonglobular interactions critical for the holotoxin
assembly, stability, and cytotoxicity. Mutational analysis of
the surface exposed residues of the aromatic patch and the
groove shows that these two elements are critical to cell
surface binding and toxicity.
Received August 12, 2005; Accepted October 12, 2005; Published November 18,
2005
DOI: 10.1371/journal.ppat.0010028
Copyright:  2005 Nesic and Stebbins. This is an open-access article distributed
under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original author and source are credited.
Abbreviations: CDT, cytolethal distending toxin; DTT, dithiothreitol
Editor: Jorge Galan, Yale University, United States of America
* To whom correspondence should be addressed. E-mail: stebbins@rockefeller.edu
PLoS Pathogens | www.plospathogens.org November 2005 | Volume 1 | Issue 3 | e28 0214Results
The Role of CdtA Nonglobular Interactions
We recently determined the crystal structure of Haemophi-
lus ducreyi CDT [16]. The structure revealed that the toxin is
composed of three different subunits (Figure 1A): CdtA and
CdtC, which both exhibit a lectin-type fold, and CdtB, which
is a DNase I-like nuclease. All three subunits interact
intimately with each other, forming three extensive globular
protein-protein interfaces. In addition, CdtA and CdtC each
have extended, nonglobular polypeptides at their N- and C-
termini, and in both proteins these regions interact with
other elements of the holotoxin to cement the assembly of the
ternary complex. These four nonglobular extensions, or
‘‘tails,’’ account for nearly a third of the surface area buried
upon complex formation. These tails, therefore, likely
contribute signiﬁcantly to the stability of the ternary
complex. By creating a series of deletion mutants, we have
examined the role of the CdtA and CdtC ‘‘tails’’ in holotoxin
assembly and activity.
The N-terminus of CdtA is particularly interesting.
Residues 18 56 are disordered and invisible in the crystal
structure, and we sought to determine their contribution to
the assembly and activity of the holotoxin. The amino acids
56 67 of CdtA make only minor contacts with other subunits
within a single holotoxin complex, but instead interact with
the groove of an adjacent holotoxin complex in the crystals
[16]. The amino acids 67 75 of CdtA, however, do contact
CdtB and CdtC in the appropriate complex in the crystal and
therefore represent a more realistic structural interaction.
Therefore, we created three N-terminal deletions of CdtA
(D18 56, D18 67, D18 75) and examined them for complex
assembly and toxin activity.
All mutants with N-terminal deletions of CdtA were
successfully puriﬁed and refolded into CDT complex. The
complex integrity in all cases was preserved during ion-
exchange chromatography (Figure 2). The refolded com-
plexes were loaded on a cation-exchange column (SP
Sepharose Fast Flow; GE Healthcare, Piscataway, New Jersey,
United States) at 40 mM NaCl concentration and eluted by
gradual increase of salt concentration (from 0 mM to 500 mM
NaCl). The CDT holotoxin, wild-type and all mutants, elutes
between 100 mM and 150 mM NaCl. In addition, in some
preparations even in the case of the wild-type complex, we
observed a second peak eluting at concentrations higher than
200 mM NaCl. This peak was composed of the CdtB subunit
only, the only CDT subunit that binds to SP Sepharose under
these conditions (data not shown). That is not unexpected as
the calculated pI of CdtB is fairly basic at 8.5, whereas CdtA
and CdtC have acidic pIs of 5.58 and 6.21, respectively. It is
possible that single peak of CdtB is due to excess CdtB
protein in the refolding reactions that refolded apart from
CdtA and CdtC, which then binds more strongly to the
cation-exchange resin than the holotoxin with the acidic
lectin domains. It is also possible that the cation-exchange
column destabilizes the CDT holotoxin to some degree,
leading to an increase in the ‘‘CdtB peak.’’ CdtA and CdtC
were present in the ﬂow through of the column as well, and
this is what we observed with CDT holotoxin with D18 75
truncation of CdtA (Figure 2D). Moreover, when refolded in
the absence of CdtB, CdtA and CdtC do not bind the resin
under these conditions (data not shown).
On a Superdex 200 gel ﬁltration column (GE Healthcare),
using a gel ﬁltration buffer containing 200 mM NaCl, 20 mM
HEPES (pH 7.5), 2.5 mM dithiothreitol (DTT) (Figure 3A), all
CdtA deletion mutants that were refolded into a CDT
holotoxin were shifted signiﬁcantly to a lower molecular
weight in gel ﬁltration (Figure 3A). At the same time, all three
subunits appear in a stoichiometric ratio in the peak
fractions (Figure 3B). Moreover, all of these deletions of
CdtA do not reduce the toxicity of the holotoxin, as measured
by cell cycle arrest of holotoxin-treated cells (Figure 3C). One
explanation for the discrepancy between the results for
biochemical assembly and activity of the CdtA N-terminal
deletion mutants would be to postulate an enhanced
stabilization of the ternary complex upon interaction with a
cell surface ligand. Indeed, gel ﬁltration chromatography is a
more demanding assay for complex stability than other
chromatographic methods, and the three CdtA deletion
mutants discussed above all co-puriﬁed by ion-exchange
chromatography (Figure 2).
As an alternative to demonstrate complex formation, we
have performed co-immunoprecipitation experiments. A
Myc-tagged CdtC subunit was refolded together with wild-
type CdtB and wild-type or deletion mutants of CdtA and
subjected to ion-exchange and size exclusion chromatogra-
phy. Gel ﬁltration fractions were then subjected to immuno-
precipitation with anti-MYC antibody. They were all able to
co-immunoprecipitate, demonstrating that the subunits were
still able to form complexes (Figure 4A) despite their
disassembly during gel ﬁltration chromatography. Nonspe-
ciﬁc binding to protein G Sepharose was not detected (Figure
4B). All of these experiments suggest that contacts that the
residues 18 75 of N-terminus CdtA make with other subunits
contribute to the holotoxin stability, but they are not critical
for complex formation and toxin activity.
The C-terminus of CdtA extends to CdtC and binds by
forming an intermolecular b-sheet, whereas the C-terminal
extension of CdtC interacts with both CdtA and CdtB (Figure
1 A ) .T h eC d t AC - t e r m i n u sp o s s e s s e sam o r ee x t e n s i v e
interaction than the N-terminal region of this subunit, and
it might be expected that deletions of this region would have
a more pronounced effect. This is indeed the case, as removal
of this polypeptide (CdtAD215 223) leads to an inability of
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Synopsis
The cytolethal distending toxin is used by many bacteria to damage
the DNA of infected organisms. This DNA damage prevents cells
from dividing and eventually leads to cell death, which raises the
possibility that this genomic damage may be a contributing factor
to carcinogenesis. The cytolethal distending toxin is composed of
three proteins that form a tightly associated complex. After
secretion by the bacterium, two proteins in this complex adhere
to the cell surface and achieve the delivery of the third protein into
the cell, where it causes DNA lesions. This report examines how this
toxin is assembled and how it adheres to host cell surfaces. A set of
molecular features on the toxin is shown to be critical for this cell
adherence and for the ability of the cytolethal distending toxin to
inhibit cell division. These results tie together for the first time
aspects of the molecular structure of the cytolethal distending toxin
and its ability to adhere to host cell surfaces, contributing to
mechanistic understanding of the activity of this genotoxin.the complex to co-refold and to a precipitation of CdtA (data
not shown).
The Role of CdtC Nonglobular Interactions
We also made a series of deletion mutants of the CdtC N-
and C- terminal tails, which demonstrate that the non-
globular interactions of CdtC with both CdtA and CdtB
strongly contribute to toxin assembly, stability, and activity.
The N-terminal 13 amino acids of CdtC interact with active
site residues of CdtB, and we have previously shown that these
interactions play an autoinhibitory role in holotoxin activity
in vitro [16]. We have previously shown that CdtCD(21 35)
assembles into a biochemically stable holotoxin, and it is as
active as the wild-type complex in toxicity assays [16]. A
slightly larger deletion, CdtCD(21 39), which removes several
residues that make a small number of additional contacts to
CdtB and CdtA, destabilizes the complex. The mutant
complex still co-puriﬁes by cation-exchange chromatography,
but there is a signiﬁcant decrease in the holotoxin stability
(Figure 6C). This is also evident by gel ﬁltration chromatog-
raphy (Figure 5A and 5B). This leads to impaired toxicity of
the mutant holotoxin as determined by analysis of cell cycle
of holotoxin-treated cells (Figure 5C).
As the C-terminal tail of CdtC interacts with both CdtA and
CdtB, it is expected that its removal would undermine
complex stability and decrease toxicity. CdtCD179 186,
which deletes residues at the C-terminus that are not visible
in the crystals, partially destabilizes the holotoxin assembly, as
judged by gel ﬁltration and ion-exchange chromatography
(Figures 5A and 6D), and signiﬁcantly reduces toxicity against
cells (Figure 5C). It is not possible with these data to
determine whether the decrease in toxicity is due to partial
destabilization of the ternary complex or to a role of the
CdtC C-terminus in receptor binding. A larger C-terminal
deletion, CdtCD169 186, presents a much more forceful
phenotype, as it does not productively refold, indicating that
the loss of residues 169 178, which make contact with both
CdtA and CdtB, more signiﬁcantly destabilizes the assembly
of the ternary complex (data not shown).
Structural Basis of Cell Surface Binding
CdtA and CdtC have many similarities to the ricin B-chain
in fold and in placement with respect to the active subunit
Figure 1. Structure of CDT and Mutational Locations
Four alternative orientations of the crystal structure of the H. ducreyi CDT are shown as a ribbon cartoon tracing the three polypeptide chains. CdtA,
CdtB, and CdtC are shown in blue, red, and green, respectively. Red dots indicate CdtB peptide not modeled due to disorder. N, NH2-terminus; C, COOH-
terminus. The final image shows a partially transparent surface illustration focusing on the groove (red) and aromatic patch (yellow). Residues mutated
for cell binding studies are indicated in white.
DOI: 10.1371/journal.ppat.0010028.g001
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expected that these two subunits of CDT will have a function
in host cell binding and internalization of the toxin. Several
reports indicate that these subunits can adhere to cell
surfaces [11,21 23]. The crystal structure shows that CdtA
and CdtC together contribute toward the formation of two
notable surfaces, a cluster of highly conserved aromatic
residues, and a long and deep groove that is formed at the
interface of two subunits (Figure 1B). These may represent
regions responsible for cell contact and attachment. To
address this possibility, we have altered these molecular
surfaces by mutagenesis and examined mutant holotoxins for
binding to cells and effectiveness to induce cell cycle arrest.
In order to be able to determine if different mutant
holotoxins interact with the cells, we have developed a
ﬂuorescence-based binding assay. The holotoxin was ﬂuo-
rescently labeled with Alexa Fluor 488 ﬂuorescent dye
(Molecular Probes, Eugene, Oregon, United States). The
Alexa Fluor 488 reactive dye has a tetraﬂuorophenyl ester
moiety that reacts efﬁciently with primary amines of proteins
to form stable dye-protein conjugates. It was necessary to test
the activity of CDT-Alexa Fluor conjugate in a cellular
intoxication assay, since there are reports suggesting that
biotin labeling of CdtA disrupted complex formation and led
to a reduction in toxicity [22]. Dye-conjugated CDT was as
potent as unconjugated toxin and caused a comparable level
of G2/M arrest of HeLa cells (Figure 7A). This enabled us to
test the binding of ﬂuorescently labeled holotoxin to HeLa
cells by ﬂow cytometry and confocal microscopy. Flow
cytometry gave a quantitative evaluation of holotoxin bind-
ing, whereas confocal microscopy provided qualitative visual-
ization of the cytometry results, while also revealing the
localization of bound holotoxin. The labeled holotoxin
speciﬁcally binds to cells in a manner easily detectable over
background.
We have previously demonstrated that a quadruple
aromatic patch mutant (W91G/W98G/W100G/Y102A) is in-
capable of intoxicating cells [16] (Figure 8B) and postulated
that this prominent structural element could be involved in
cell surface interactions. Using a ﬂuorescence-based cell
binding assay, we were able to show that this mutant is indeed
incapable of binding to HeLa cells. By both ﬂow cytometry
and confocal microscopy, we were not able to detect any
signiﬁcant binding of the aromatic patch mutant above
background (Figures 7B and 9). This shows that the aromatic
patch residues are vital for cell surface attachment. A triple
aromatic mutant (W98G/W100G/Y102A) behaves in the same
way as the quadruple (Figure 8B).
We also mutagenized the extended groove formed by CdtA
and CdtC to assess its importance. The groove mutant
contains two mutations in CdtA (P103A and Y106A) and
two in CdtC (R43K and Q49A). The rationale for these
Figure 2. Cation-Exchange Chromatography of the CDT Holotoxin Containing N-Terminal Deletions of CdtA
Wild-type (A) or mutant CDT holotoxins [(B) holotoxin with CdtA (D18–56), (C) holotoxin with CdtA (D18–67), (D) holotoxin with CdtA (D18–75)] were
run on Fast Flow SP Sepharose columns using an A ¨KTA FPLC. Refolded CDT complexes were loaded and examined in a salt gradient as described in
Materials and Methods. Individual fractions (5 ml) or pooled material from the elution peak were collected and examined by SDS-PAGE. Proteins were
stained with Coomassie blue stain. Images of the gels are presented inside corresponding chromatograms. L, loaded material; fr, fraction number; Fl,
flowthrough; P, pooled material from elution peak. Absorbance was measured at 280 nm.
DOI: 10.1371/journal.ppat.0010028.g002
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and that also interact with the N-terminal tail of the
symmetry-related CdtA molecule. The quadruple groove
mutant did not affect complex stability as judged by ion-
exchange (data not shown) and gel ﬁltration chromatography
(Figure 8A). However, the biological activity of the mutant
holotoxin was signiﬁcantly impaired (Figure 8B). We have
examined the ability of the groove mutant to induce cell cycle
arrest on HeLa cells using two different concentrations and
found that the percentage of cells that arrest in G2/M is
diminished at a 10 ng/ml concentration of toxin (compare
wild-type [68.98%] and groove mutant [48.52%]), and it was
almost undetectable at 1 ng/ml (the concentration that is
usually sufﬁcient to cause signiﬁcant cell cycle arrest with the
wild-type holotoxin). To characterize this mutant in more
detail, we examined it in binding assays. Alexa Fluor
488 conjugated groove mutant exhibited noticeably dimin-
ished binding to HeLa cells as determined by both ﬂow
cytometry (Figure 7B) and confocal microscopy (Figure 9). It
should be noted that the degree of labeling of the mutant
CDT holotoxins was slightly higher than that of the wild-type
CDT (see Materials and Methods), which excludes the
possibility that lack of detection of binding was due to
weaker ﬂuorescent labeling. Therefore, these ﬁndings identify
the groove as a second critical cell-contacting region of the
holotoxin.
Discussion
Lara-Tejero and Galan [18] initially proposed that CDT
represents an ‘‘AB’’ type of toxin in which CdtB serves as the
‘‘A,’’ or active, subunit, and CdtA and CdtC represent a
heterodimeric ‘‘B,’’ or binding, subunit. The crystal structure
of the H. ducreyi CDT holotoxin strongly substantiated that
Figure 3. Effects of N-Terminal Deletions of CdtA on Holotoxin Integrity and Toxicity
(A) Size exclusion chromatography profile of CDT holotoxin containing wild-type or deletion mutants of CdtA, wild-type CdtB, and myc-tagged CdtC.
Following cation-exchange chromatography, 2-ml samples were injected onto a Superdex 200 HiLoad 16/60 column and run at flow rate of 2 ml/min in
200 mM NaCl, 20 mM HEPES (pH 7.5), and 2.5 mM DTT on an A ¨KTA FPLC. Fractions of 2 ml were collected. Calculated molecular weights of globular
proteins eluting at the same elution volumes are indicated in parentheses.
(B) Peak fractions were analyzed by SDS-PAGE, and CDT subunits were visualized with Coomassie blue stain. A, CdtA; B, CdtB; C, CdtC; A*, deletion
mutants of CdtA.
(C) Cell cycle analysis of HeLa cells exposed to 1 ng/ml concentration of the wild-type or mutant holotoxin for 3 hr at 37 8C, 5% CO2. Cells were
processed 48 hr after holotoxin treatment, and DNA content was measured by flow cytometry. The calculated percentages of cells in G0/G1, S, and G2/
M are shown.
DOI: 10.1371/journal.ppat.0010028.g003
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proposed that CDT travels from the plasma membrane
through an endocytic pathway and then enters the Golgi
network and endoplasmic reticulum, after which CdtB
translocates directly into the nucleus [27], or is delivered by
retrograde transport into the cytosol, and then translocates
into the nucleus [17 20]. In order to try to elucidate the role
of CdtA and CdtC in the toxin assembly and cellular binding,
we have addressed the contribution of several critical
structural elements of these molecules by biochemical and
cellular assays.
Using deletion mutagenesis, we examined the role of
several nonglobular interactions in toxin stability and
function. We found that contacts of C-terminal tails of CdtA
Figure 4. Immunoprecipitation of CDT Complexes Containing Deletion Mutants of CdtA
(A) The complexes (10 lg each) were immunoprecipitated with 10 lg anti-myc antibody (myc tag was fused to C-terminus of CdtC) in 150 mM NaCl, 20
mM HEPES (pH 7.5), 0.1% Nonidet P40 substitute, followed by exposure to protein G Sepharose beads, and subjected to nondenaturing SDS-PAGE.
(B) Nonspecific binding of CDT complexes to protein G Sepharose was not detected under the same experimental conditions. A, CdtA; B, CdtB; C, CdtC;
A*, truncated CdtA; A1, holotoxin with CdtA D18 56; A2, holotoxin with CdtA D18 67; A3, holotoxin with CdtA D18 75; WT, wild-type; Ab, only anti-
myc antibody, no CDT; IgG (HþL), nonreduced immunoglobulin G; IgG H, immunoglobulin G heavy chain; IgG L, immunoglobulin G light chain; SN,
supernatant.
DOI: 10.1371/journal.ppat.0010028.g004
Figure 5. Effects of N- and C-Terminal Deletions of CdtC on Holotoxin Integrity and Toxicity
(A) Size exclusion chromatography of recombinant holotoxin containing different CdtC mutants. After cation-exchange chromatography, 2-ml CDT
holotoxin samples were injected onto a Superdex 200 HR 10/30 column and run at flow rate of 0.5 ml/min in 200 mM NaCl, 20 mM HEPES (pH 7.5), 2.5
mM DTT on an A ¨KTA FPLC. Fractions of 1 ml were collected.
(B) Following elution from the gel filtration column, several peak fractions were subjected to SDS-PAGE and CDT subunits visualized with Coomassie
blue stain. A, CdtA; B, CdtB; C, cdtC; C*, deletion mutants of CdtC.
(C) Cell cycle analysis of HeLa cells exposed to 1 ng/ml concentration of either wild-type or mutant holotoxin for 3 hr at 37 8C, 5% CO2. Cells were
processed 48 hr after holotoxin treatment, and DNA content was measured by flow cytometry. The calculated percentages of cells in G0/G1, S, and G2/
M are shown.
DOI: 10.1371/journal.ppat.0010028.g005
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Their removal results in the poor refolding of the holotoxin,
destabilization, and, as a consequence, inefﬁcient cellular
intoxication. The N-terminal tail of CdtC is deeply inserted
into the active site of CdtB, which may contribute to overall
stability of the complex. Interestingly, the truncation of 35
amino acids from the N-terminus of CdtC does not disturb
complex stability, but removal of just four more residues
leads to destabilization of the holotoxin and impaired
toxicity. On the other hand, the N-terminal tail of CdtA
makes only a few contacts with other subunits, which appear
to be inconsequential for the CdtA function in the holotoxin.
Although removal of up to 75 residues from N-terminal tail of
CdtA destabilizes the complex under gel ﬁltration conditions,
truncated mutants are still as potent as the wild-type
holotoxin against target cells. This ﬁnding is in agreement
with previous observations that deletion 19 49 of closely
related Actinobacillus actinomycetemcomitans CdtA [28] or, in
another report, the ﬁrst 59 residues [29] are dispensable for
holotoxin activity. Moreover, several groups have demon-
strated that some preparations of holotoxin actually contain
truncated CdtA [25,30]. In other bacterial pathogens, the
region N-terminal to ricin fold of CdtA is very diverse and
much longer than in H. ducreyi. It is possible that these long N-
terminal tails play a role in the assembly and translocation of
the holotoxin in bacterial cells.
Recently, several studies examined the binding of CDT
subunits to target cells and addressed the role of both CdtA
and CdtC. The results were somewhat conﬂicting in the
conclusion of what contribution CdtC made to this process.
While several groups have shown that both CdtA and CdtC
can bind to the surface of HeLa cells and that preincubation
with CdtA-CdtC complex can inhibit subsequent intoxication
with holotoxin [21 24], others have observed only binding of
CdtA to Chinese hamster ovary cells [11]. Furthermore, it was
suggested that CdtA and CdtC might bind to the same cellular
receptor [22,23]. The crystal structure of H. ducreyi CDT
holotoxin demonstrated that both CdtA and CdtC are lectin-
type structures, and they both contribute to the formation of
two prominent molecular surfaces that could be involved in
cellular interactions. The ﬁrst is a region composed of highly
conserved, surface-exposed aromatic residues. We have
previously shown that mutations of four CdtA aromatic
residues (W91G, W98G, W100G, Y102A) abolish the holotoxin
activity [16]. Here, using ﬂuorescence-based binding experi-
ments, we were able to demonstrate that these residues are
Figure 6. Cation-Exchange Chromatography of CDT Holotoxin Containing N- and C-Terminal Deletions of CdtC
Wild-type (A) or mutant CDT holotoxins [(B) holotoxin with CdtC (D21 35), (C) holotoxin with CdtC (D21 39), (D) holotoxin with CdtC (D179 186)] were
run on Fast Flow SP Sepharose columns (20 ml) using an A ¨KTA FPLC. Refolded CDT complexes were loaded on an SP Sepharose column in buffer
containing 40 mM NaCl, 20 mM HEPES (pH 7.5), 2.5 mM DTT and analyzed by a gradient in salt concentration as described in Materials and Methods.
Individual fractions (5 ml) or pooled material (P) from elution peak were collected and examined by SDS-PAGE. Proteins were stained with Coomassie
blue dye. Images of the gels are presented inside corresponding chromatograms. The peak that elutes between 100 and 150 mM NaCl concentration
(P1) contains an intact CDT holotoxin, and the second peak (P2) that elutes at concentrations higher than 200 mM NaCl contains only the CdtB subunit.
A, CdtA; B, CdtB; C, CdtC; C*, deletion mutants of CdtC; L, loaded material; fr, fraction number; Fl, flowthrough; P, pooled material from elution peak.
Absorbance was measured at 280 nm. In A, P1 contains fractions 14 22, and P2 contains fractions 31 34; in D, P1 contains fractions 20 22, and P2
contains fractions 32 34.
DOI: 10.1371/journal.ppat.0010028.g006
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ﬂuorescently labeled wild-type holotoxin to HeLa cells was
readily detectable by ﬂow cytometry and confocal micro-
scopy, binding of an Alexa Fluor 488 conjugated aromatic
mutant was undetectable in both assays. It appears that the
disruption of only three aromatic residues of CdtA (W98,
W100, Y102) is sufﬁcient to abolish cellular interactions and
abrogate holotoxin activity. It was recently shown that
Escherichia coli CdtA-II and CdtC-II can interact with
glycoproteins, and it was postulated that the putative cellular
receptor would most probably have an N-linked fucose-
containing structure [23]. It has been suggested that the
aromatic patch could be a potential carbohydrate-interacting
region [23,31], although the lipophilic nature of this cluster of
aromatic residues suggests that it may also serve to interact
with components of the plasma membrane. Indeed, it has
been recently shown that interaction of CDT with the cells is
sensitive to cholesterol depletion, and it was therefore
suggested that cholesterol-rich lipid rafts could be involved
in CDT binding [27].
We have also identiﬁed an additional cell-binding region
on the surface of the CDT holotoxin. It is represented by a
groove that is formed by CdtA and CdtC along their
molecular surfaces. Mutations of four surface-exposed groove
residues (two in CdtA:P103A/Y106A and two in CdtC:R43K/
Q49A) signiﬁcantly decrease binding to HeLa cells, which
results in the decrease in CDT toxicity. The effect of these
mutations was less severe than that of mutations of aromatic
residues, representing an intermediate phenotype. By in-
creasing concentrations of the groove mutant, it was possible
to induce more robust cell cycle arrest. In contrast, aromatic
mutants were completely incapable of causing any effect on
treated cells. This could suggest that these two regions are
involved in two independent binding events with the cell
surface.
Our ﬁndings are an important step toward a better
understanding of the molecular mechanisms underlying
CDT holotoxin assembly and interaction with the target cell
surfaces. Understanding toxin assembly and activity also
provides potential targets for pharmacological disruption of
CDT activity. Finally, the identiﬁcation of host cell surface
binding mutants of CDT provides important tools for the
identiﬁcation of host cell receptors mediating toxin entry.
Materials and Methods
Production of wild-type and mutant H. ducreyi holotoxin. H. ducreyi
CDT subunits were cloned, puriﬁed, and holotoxin complex
Figure 7. The Activity of CDT Holotoxin Labeled with Alexa Fluor 488
(A) The toxicity of CDT holotoxin labeled with Alexa Fluor 488. HeLa cells were treated with 1 ng/ml (black) or 10 ng/ml (gray) concentration of
unconjugated or Alexa Fluor 488 conjugated CDT for 3 hr at 378C, 5% CO2. Cells were processed 48 hr after holotoxin treatment, and DNA content was
measured by flow cytometry. The calculated percentages of cells in G0/G1, S, and G2/M are shown.
(B) Binding of CDT-Alexa Fluor 488 to cells. Harvested HeLa cells were exposed for 2 hr to 5 and 10 lg/ml concentration of wild-type or mutant CDT-
Alexa Fluor 488. The histogram shows the binding of 5 or 10 lg/ml concentration of wild-type and mutant CDT-Alexa Fluor 488 conjugates to HeLa
cells. Mock represents cells in buffer only (2% FCS in PBS), and control is goat anti-mouse IgG conjugated with Alexa Fluor 488, which does not bind to
HeLa cells. The level of fluorescence was analyzed by flow cytometry. The relative levels of fluorescent labeling of wild-type and mutant CDT holotoxin
was maintained to be nearly equivalent, with the mutant holotoxins (groove and aromatic patch) possessing a slightly higher level of labeling than the
wild-type (Materials and Methods).
DOI: 10.1371/journal.ppat.0010028.g007
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CDT Assembly and Cellular Interactionsreconstituted as previously described [16]. CdtA(18 223),
CdtB(23 283), and CdtC(21 186) were cloned by PCR from genomic
DNA (ATCC [American Type Culture Collection] number 700724D,
Manassas, Virginia, United States) as an N-terminal hexahistidine
fusion proteins in E. coli such that the predicted N-terminal secretion
signals were removed [32]. cdtA was cloned in pET-28a vector
(Novagen, Madison, Wisconsin, United States) with engineered in-
frame rhinovirus 3C protease recognition sequence at the 59 end of
cdtA. cdtB was cloned into an engineered version of the pac28 vector
[33], which also contains a 3C protease recognition sequence between
the hexahistidine tag and the cdtB. cdtC was cloned in the pET-21a
vector (Novagen), which has an insertion with a hexahistidine tag and
an engineered 3C protease recognition site. The three subunits were
expressed separately in BL-21 E. coli cells by the addition of 0.1 mM
isopropyl-b-D-thiogalactopyranoside (IPTG; Gold Biotechnology,
Inc., St. Louis, Missouri, United States) for 4 hr at 37 8C, 200 rpm.
The subunits were puriﬁed under denaturing conditions (8 M urea,
10 mM Tris [pH 8.0], 0.1 M Na-phosphate) using nickel chelating
afﬁnity resin (GE Healthcare). Each subunit was eluted from nickel
chelating afﬁnity resin with the elution buffer that contained 500 mM
imidazole (pH 8.0), 8 M urea, 10 mM Tris (pH 8.0), 0.1 M Na-
phosphate. The usual yields per liter of bacterial culture were 50 mg
of CdtA, 60 mg of CdtB, and 200 mg of CdtC. The CDT holotoxin was
reconstituted by co-refolding all three subunits together via dialysis
at 48C into a native buffer consisting of 20 mM HEPES (pH 7.5), 200
mM NaCl, 2.5 mM DTT, 5% glycerol, and 2 mM EDTA. The total
protein concentration during refolding was maintained under 0.1
mg/ml (20 mg of protein in 200 ml of denaturing buffer per 4 L of
native buffer), and the native buffer was changed four times within a
24-hr period. The proteins were separated from the afﬁnity tag
through site-speciﬁc proteolytic cleavage with rhinovirus 3C protease
(2 lg/ml 3C protease fused to a GST tag) for 12 hr at 4 8C. The
protease was subsequently removed by passing the material through a
Fast Flow GST-Sepharose column (GE Healthcare). The CDT
holotoxin was further puriﬁed by cation-exchange chromatography
(SP Sepharose Fast Flow, 20 ml bead volume; GE Healthcare) using an
A ¨ KTA FPLC (GE Healthcare). Refolded material was diluted ﬁve
times to lower the salt concentration to 40 mM NaCl prior to loading
the SP Sepharose column. After equilibrating the column with
washing buffer (20 mM HEPES [pH 7.5], 2.5 mM DTT), the column
was subjected to a gradient increase in salt concentration (from 0 to
500 mM NaCl in 20 mM HEPES [pH 7.5], 2.5 mM DTT during 150 min
at ﬂow rate of 3 ml/min). The remaining material was bumped from
the column with 1 M NaCl, 20 mM HEPES (pH 7.5), 2.5 mM DTT.
Individual fractions (5 ml) or pooled material from elution peak was
collected and examined by SDS-PAGE. As a ﬁnal step in the
puriﬁcation, and at the same time as a test of complex integrity,
fractions eluted from the SP Sepharose column that contained intact
CDT holotoxin were pooled together, concentrated using Centricon
Plus-20 (Millipore, Billerica, Massachusetts, United States), and run
on a gel ﬁltration column (Superdex 200 HiLoad 16/60 [120 ml] or
Superdex 200 HR 10/30 [25 ml]; GE Health), as indicated in the ﬁgure
legends. Gel ﬁltration buffers contained 200 mM NaCl, 20 mM HEPES
(pH 7.5), 2.5 mM DTT; a 2-ml sample was injected, and 2-ml (from
Superdex 200 HiLoad 16/60) or 1-ml (from Superdex 200 HR 10/30)
fractions were collected. The peak fractions were examined by SDS-
PAGE, and proteins were visualized by staining with Coomassie blue
staining solution (50% methanol, 0.05% Coomassie brilliant blue R-
50, 10% acetic acid in water) followed by destaining solution (5%
methanol, 7% acetic acid in water).
The deletion mutants were generated by PCR and inserted into the
same vector as the wild-type genes. The amino acid substitutions were
introduced into cdt genes by PCR using Pfu DNA Polymerase
(Stratagene, La Jolla, California, United States) and primers contain-
ing the appropriate base changes. The template plasmid was
subsequently removed by digestion with DpnI prior to transforma-
tion. Myc tag sequence (EQKLISEEDL) was fused in-frame to the 39
end of the wild-type cdtC gene in two subsequent PCRs using the pET-
21a-CdtC plasmid as template, a T7 promoter primer as a forward
primer in both reactions, and myc1R (59-GAGTTTCTGCTCGC
TACCCTGATTTCTTCG-39) and myc2R (59-TTACAGATCCTCTT
CAGAGATGAGTTTCTGCTCGCTACC-39) as reverse primers. The
PCR product was initially cloned into the pCR2.1 TOPO vector
(Invitrogen, Carlsbad, California, United States), and after sequence
veriﬁcation subcloned into the pET21a. Puriﬁcation of the mutant
proteins and assembly into the mutant CDT holotoxin were
performed as previously described for the wild-type complex.
Cell cycle analysis/cellular intoxication assay. As a measure of toxin
potency and cellular intoxication, we have examined by ﬂow
cytometry the cell cycle progression of HeLa cells treated with the
CDT holotoxin. HeLa cells (2310
6 cells) were treated with indicated
concentrations of wild-type or mutant CDT holotoxin for 3 hr at 37
8C, 5% CO2, and were subsequently washed of toxin and maintained
in culture media. At 48 hr after treatment with CDT, cells were
Figure 8. Effect of the Aromatic Patch and Groove Mutants on the Holotoxin Assembly and Toxicity
(A) Elution profile of the wild-type and groove mutant of the CDT holotoxin during size exclusion chromatography. Samples were loaded on a Superdex
200 HiLoad 16/60 column at a flow rate of 2 ml/min in 200 mM NaCl, 20 mM HEPES (pH 7.5), 2.5 mM DTT on A ¨KTA FPLC. Peak fractions (2 ml) were
analyzed by SDS-PAGE (15% gel), and CDT subunits were visualized with Coomassie blue staining. SDS-PAGE of the CDT holotoxin groove mutant is
shown inside gel filtration chromatogram. Elution volumes of wild-type and mutant holotoxin are shown.
(B) Cell cycle analysis of HeLa cells exposed to 1 ng/ml (gray) or 10 ng/ml (black) concentration of either wild-type or mutant holotoxin for 3 hr at 37 8C,
5% CO2. Cells were processed 48 hr after holotoxin treatment, and DNA content was measured by flow cytometry, as detailed in Materials and Methods.
The calculate percentages of cells in G0/G1, S, and G2/M are shown. CdtABC 4m Aromatic mutant (CdtA: W91G/W98G/W100G/Y102A); CdtABC 3m
Aromatic mutant (CdtA: W98G/W100G/Y102A); CdtABC groove mutant (CdtA: P103A/Y106A, CdtC: R43K/Q49A).
DOI: 10.1371/journal.ppat.0010028.g008
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CDT Assembly and Cellular Interactionsharvested, ﬁxed by the addition of cold 70% ethanol during
continuous vortexing, and left at 4 8C for 16 hr. The cells were then
stained for 2 hr at 23 8C with propidium iodide solution (25 lg/ml
propidium iodide, 100 U/ml DNase-free RNase A, 0.04% Triton X-100
in PBS). Relative DNA content was measured by ﬂow cytometry with
an FACSCalibur ﬂow cytometer (Becton-Dickinson, Palo Alto,
California, United States). The data were collected from 20,000 cells,
and analysis was performed with Cell Quest software.
Labeling of the CDT holotoxin with Alexa Fluor 488 ﬂuorescent
dye and ﬂow cytometry. The CDT holotoxin was conjugated with
Alexa Fluor 488 dye using the Alexa Fluor 488 Monoclonal Antibody
Labeling Kit (Molecular Probes) according to the manufacturer’s
instructions. Brieﬂy, 100 lg of CDT holotoxin in PBS/0.1 M sodium
bicarbonate (1 mg/ml ﬁnal protein concentration) was added to the
vial of reactive dye and incubated overnight at 4 8C on a rotator
shaker. Labeled protein complex is then separated from uncon-
jugated dye using a puriﬁcation resin supplied by manufacturer. The
degree of labeling was determined by measuring the absorbance at
280 nm and 494 nm using a NanoDrop ND-1000 spectrophotometer
(Wilmington, Delaware, United States) and calculating the protein
concentration and the ﬂuorescent dye concentration using Protein &
Labels module of ND-1000 software. The degree of labeling was
calculated as moles of dye per mole of protein. This produced
calculations of labeling of 2.98 6 0.11 for wild-type CdtABC, 3.99 6
0.32 for groove mutant CdtABC, and 5.64 6 0.33 for aromatic
mutant. Goat anti-mouse IgG was purchased already conjugated with
Alexa 488 (Molecular Probes), and the degree of labeling was 6.4
moles of dye per mole of protein.
Binding of ﬂuorescently labeled CDT holotoxin to HeLa cells was
determined by ﬂow cytometry. HeLa cells (1 3 10
6) were harvested,
washed twice with PBS, and incubated for 2 hr at room temperature
with indicated amounts of wild-type or mutant CDT holotoxin in 2%
FCS/PBS. Goat anti-mouse IgG antibody conjugated with Alexa Fluor
488 (Molecular Probes) was used as a negative control. Samples were
washed three times with PBS and ﬁxed with 1% formaldehyde
(Polysciences, Inc., Warrington, Pennsylvania, United States) in PBS
prior analysis. The presence of green ﬂuorescence on HeLa cells was
measured by ﬂow cytometry using an FACSCalibur ﬂow cytometer
(Becton-Dickinson). Analysis was performed with Cell Quest software.
Immunoprecipitation of CDT complexes. CDT complexes com-
posed of either mutant or wild-type CdtA, wild-type CdtB, and CdtC
fused in-frame with myc tag at the C-terminus were immunoprecipi-
tated using an anti-myc antibody (9E10; Santa Cruz Biotechnology,
Santa Cruz, California, United States). Then, 10 lg of protein
complex was incubated with 10 lg of antibody in binding buffer (20
mM HEPES [pH 7.5], 150 mM NaCl, 0.1% Nonidet P40 Substitute
[Sigma, St. Louis, Missouri, United States]) for 3 hr at 4 8C. Immune
complexes were incubated with protein G Sepharose 4 Fast Flow
(Molecular Probes) in the binding buffer for additional 3 hr at 4 8C.
Immunoprecipitates were collected by centrifugation, washed ﬁve
times with binding buffer, and resuspended in nonreducing sample
buffer (2% SDS, 50 mM Tris-Cl [pH 6.8], 0.1% bromophenol blue,
10% glycerol). The samples were boiled for 3 min at 95 8C, brieﬂy
centrifuged, and subjected to SDS-PAGE. Protein gels were stained
with Coomassie blue dye. Nonreducing conditions were used to
minimize dissociation of heavy and light immunoglobulin chains,
which masked CDT subunits on a Coomassie blue stained gel. It was
not possible to avoid complete separation of the immunoglobulin
chains due to the fact that CDT complexes were already in the buffer
with DTT.
Confocal microscopy. HeLa cells, cultured directly on microscope
cover glass, were treated with 5 lg/ml concentration of mutant or
wild-type CDT holotoxin labeled with Alexa Fluor 488 in PBS buffer
containing 3% BSA and Hoechst 33258 dye (1:500) (Sigma). Following
treatment, cells were washed three times with PBS and ﬁxed by
incubation in 3.7% formaldehyde for 15 min at room temperature.
Fixative was replaced with PBS, and samples were mounted with
ProLong Gold Antifade Reagent (Molecular Probes). Samples were
dried for at least 48 hr prior to examination under inverted LSM510
confocal microscope (inverted Zeiss Axiovert 200 microscope,
Thornwood, New York, United States) using 360 objective lenses.
Images were collected and analyzed using LSM510 software (Zeiss).
Supporting Information
Accession Numbers
The GenBank (http://www.ncbi.nlm.nih.gov/Genbank) accession num-
ber for Haemophilus ducreyi CDT is U53215. The Protein Data Bank
(http://www.rcsb.org/pdb) accession number for the crystal structure
of H. ducreyi CDT is 1SR4 and is shown in Figure 1.
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